Cadi­la's ster­ile in­jectable site in In­dia hit with a Form 483 fol­low­ing a rare in­ter­na­tion­al in­spec­tion for FDA

Fol­low­ing a 10-day in­spec­tion in late Feb­ru­ary and ear­ly this month, the FDA has sent a Form 483 with sev­er­al con­cern­ing ob­ser­va­tions to Cadi­la Health­care’ …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER